COMMUNIQUÉS West-GlobeNewswire

Intercept Reports Additional Positive Data from REGENERATE, the First Successful Phase 3 Study in NASH
11/04/2019
OCA significantly improved fibrosis in patients with liver fibrosis due to NASH and demonstrated consistent efficacy across multiple histologic and biochemical parameters REGENERATE data to be presented during the [...]
Solo Growth Announces Listing on Frankfurt Stock Exchange
11/04/2019
CALGARY, Alberta, April 11, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS TM with the vision to become a premier [...]
Autolus Announces Pricing of Public Offering
11/04/2019
LONDON, April 10, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of an [...]
JDRF Canada is extremely pleased with the House of Commons Standing Committee on Health report on a Diabetes Strategy for Canada
11/04/2019
OTTAWA, April 10, 2019 (GLOBE NEWSWIRE) -- JDRF is very pleased with the 11 recommendations made today by the House of Commons Standing Committee on Health in their report: A Diabetes Strategy for Canada , in alignment [...]
Galapagos creates new warrant plans
10/04/2019
Mechelen, Belgium; 10 April 2019, 22.01 CET; regulated information -- Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its b oard of directors created 2,070,000 warrants under new warrant plans for the [...]
Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019
10/04/2019
CINCINNATI, April 10, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report second quarter 2019 financial results [...]
Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019
10/04/2019
SAN DIEGO, April 10, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL) announced that it had filed its quarterly report on Form 10-Q today. The report was filed earlier than usual to facilitate the closing of [...]
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
10/04/2019
RALEIGH, N.C., April 10, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI” or the “Company”) today announced that it is commencing an underwritten public offering of shares of [...]
Rexahn Announces Reverse Stock Split
10/04/2019
ROCKVILLE, Md., April 10, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers [...]
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
10/04/2019
Long-term revenue potential of over $75 million for NME with IP protection through 2031 Leverages existing commercial capabilities to provide a novel treatment option for OIC Total 2019 Company Net Sales expected to be [...]
Spring Bank to Host a Conference Call to Discuss Inarigivir Data Presented at the International Liver Congress™ (EASL 2019)
10/04/2019
Conference call to be held on Friday, April 12 at 8:00am EDT HOPKINTON, Mass., April 10, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing [...]
Oncology Venture today publishes a supplement to the prospectus published April 5, 2019
10/04/2019
Press release Oncology Venture A/S hereby announces a supplement to the prospectus published April 5, 2019 regarding a rights issue. As further described in the supplement, Oncology Venture A/S has obtained additional [...]
Athersys to Host First Quarter Financial Results Call
10/04/2019
CLEVELAND, April 10, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, May 8, 2019, and will host a [...]
Dr. Atiyeh Emam has been awarded the status of Top Dentist by Washingtonian Magazine
10/04/2019
LANSDOWNE, Va., April 10, 2019 (GLOBE NEWSWIRE) -- Dr. Atiyeh Emam has been awarded the status of Top Dentist by Washingtonian Magazine. The Washingtonian was founded in 1965 by Robert J. Myers and Laughlin Phillips. [...]
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
10/04/2019
Basel, Switzerland, April 10, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reported that shareholders approved all proposals of the Board of Directors at today’s Annual General Meeting (AGM) for the financial year 2018 [...]
CareDx Accuses Natera of False Advertising Claims That Mislead Medical Personnel and Transplant Patients
10/04/2019
CareDx Files Second Lawsuit Against Natera BRISBANE, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ [...]
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
10/04/2019
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of an authorized Canadian distribution agreement with [...]
Information regarding the total number of voting rights and total number of shares of the Company
10/04/2019
Information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social
10/04/2019
Information relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code [...]

Pages